Biotech Stocks Pressured, Again (IBB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailBiotech stocks declined early on Thursday, with iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) lower by about 3%. The group is down over 10% in the past month.
Notable decliners included popular stocks like Pharmacyclics Inc. (Nasdaq: PCYC), Gilead Sciences Inc. (Nasdaq: GILD), Biogen Idec Inc. (Nasdaq: BIIB) and Celgene Corporation (Nasdaq: CELG), to name a few.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cable ONE (CABO) halted on volatility
- Trump says Russia to immediately supply 300,000 tons of diesel fuel
- Citi keeps neutral rating on Helmerich & Payne with $48 target
Create E-mail Alert Related Categories
ETFs, General News, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
